Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/16/2013 | CN103349648A Tamoxifen citrate enteric-coated tablets |
10/16/2013 | CN103349647A Tamoxifen citrate sustained-release granules |
10/16/2013 | CN103349646A Medicinal composition containing cefaclor particles, and preparation method and application thereof |
10/16/2013 | CN103349645A Stabilized micronised particles |
10/16/2013 | CN103349644A Lansoprazole complex micelle medicine composition for injection and preparation method thereof |
10/16/2013 | CN103349184A Compositions and methods for enhancing the antioxidant status of animals |
10/16/2013 | CN102973531B Levetiracetam medicine composition and preparation method thereof |
10/16/2013 | CN102973516B Method for preparing monensin premix |
10/16/2013 | CN102935119B Method for preparing ointment for treating lumbar disc herniation |
10/16/2013 | CN102895182B Method for preparing cefoxitin sodium for injection |
10/16/2013 | CN102895181B Method for preparing mezlocillin sodium for injection |
10/16/2013 | CN102872438B Traditional Chinese medicine preparation for treating sea crab intoxication |
10/16/2013 | CN102872149B Application of Houttuynoid B in medicament for treating cecum cancer |
10/16/2013 | CN102846641B Compound sulfachlorpyridazine sodium powder for preventing and treating pasteurella infection of livestock and poultry |
10/16/2013 | CN102813910B Medicine composition used for controlling poultry airsacculitis, and preparation method thereof |
10/16/2013 | CN102755617B External medicinal liquor for use in ear point channels-collaterals therapy |
10/16/2013 | CN102755308B Application of basic fuchsin in preparation of medicament for treating gastric ulcer |
10/16/2013 | CN102755290B Medicine composition containing ibuprofen |
10/16/2013 | CN102716092B Formula of aureomycin hydrochloride premix granule and granulating process |
10/16/2013 | CN102716074B Bimatoprost eye drops and preparation method thereof |
10/16/2013 | CN102688184B Preparation method of ephedrine hydrochloride injection for improving rat blood rheological obstacle |
10/16/2013 | CN102670670B Preparation method of ginkgo dipyridolum injection with high content of ginkgo terpene lactones |
10/16/2013 | CN102665712B Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester |
10/16/2013 | CN102641458B Preparation method for medicated implanted catgut sutures for treating neck, shoulder, waist and leg pain and spinal diseases |
10/16/2013 | CN102641242B Method for preparing composite phospholipid sterol lipid |
10/16/2013 | CN102631350B Compound preparation of quetiapine fumarate and lurasidone |
10/16/2013 | CN102626408B Application of isatin thiosemicarbazone compound in inhibition of NDM-1 activity |
10/16/2013 | CN102617584B Irinotecan hydrochloride compound and medicinal composition thereof |
10/16/2013 | CN102614155B Mixed litholytic agent for dissolving cholesterol stone |
10/16/2013 | CN102614149B Method for preparing sinomenine capsules |
10/16/2013 | CN102614122B Ketorolac tromethamine nasal cavity spraying agent and preparation method thereof |
10/16/2013 | CN102614108B Cubic water quality liquid crystal gel transdermic absorption preparation containing oxybutynin chloride and preparing method thereof |
10/16/2013 | CN102600435B Device and formula of traditional Chinese medicine for stabilizing heart and relieving asthma |
10/16/2013 | CN102579579B Medicine composition for anaesthetic pain relief after crissum operation |
10/16/2013 | CN102579445B Application of sinomenine or pharmaceutically acceptable salt thereof as medicament for preventing and treating pulmonary interstitial fibrosis |
10/16/2013 | CN102579409B Donepezil transdermal patch |
10/16/2013 | CN102552405B Method for preparing medicinal composition for perianal anaesthetic analgesia of postoperation |
10/16/2013 | CN102552245B Composition containing epigallocatechin gallate and taxol for suppressing tumor cell proliferation |
10/16/2013 | CN102512516B Medicinal moxa roll for treating mammary gland tumors and preparation method thereof |
10/16/2013 | CN102499923B Drug combination, as well as preparation method and application of same |
10/16/2013 | CN102491935B Nitrobenzaldehyde indole schiff base, preparation method and application thereof |
10/16/2013 | CN102470121B Pharmaceutical compositions comprising dronedarone |
10/16/2013 | CN102432760B Quaternary amine konjac glucomannan adduct, its preparation method and application |
10/16/2013 | CN102429986B Traditional Chinese ointment for treating burn and scald and preparation method thereof |
10/16/2013 | CN102421778B Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
10/16/2013 | CN102372741B Zoledronic acid crystal and lyophilized powder injection thereof |
10/16/2013 | CN102351886B Cefteram pivoxil crystal and preparation method thereof and composition tablets containing crystal |
10/16/2013 | CN102344458B Cefprozil compound crystal and medicinal composition thereof |
10/16/2013 | CN102344371B Temperature-sensing amphiphilic polyether dendrons and their preparation method and use |
10/16/2013 | CN102335165B Application of flavonoids compounds in breast cancer resistance |
10/16/2013 | CN102311471B Levorotary isovaleryl spiramycin II as well as preparation, preparation method and application thereof |
10/16/2013 | CN102307579B Pharmaceutical composition for oral administration |
10/16/2013 | CN102302512B Multi-vitamin mineral tablet |
10/16/2013 | CN102277398B Process for preparing modified pectin with high bioavailability and antitumor application of modified pectin |
10/16/2013 | CN102276597B 14-membered macrolide epothilone compounds and application thereof |
10/16/2013 | CN102272134B Modulators of toll-like receptors |
10/16/2013 | CN102250099B Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
10/16/2013 | CN102250022B Substituted quinoxalinamine compounds, and preparation method and application thereof |
10/16/2013 | CN102241969B Small-molecule fluorescent probes for quinazoline alpha1-adrenergic receptors and application of small-molecule fluorescent probes |
10/16/2013 | CN102238944B A method for the production of bioadhesive compact matrices |
10/16/2013 | CN102215850B A composition comprising extraction of fucoxanthin |
10/16/2013 | CN102210866B Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect |
10/16/2013 | CN102196805B Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
10/16/2013 | CN102151253B Nifedipine osmotic pump type controlled release tablet |
10/16/2013 | CN102138888B Alprostadil lipid nanosphere gel and preparation method thereof |
10/16/2013 | CN102114012B Medicinal composition for treating heart cerebrovascular diseases as well as preparation method and application thereof |
10/16/2013 | CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents |
10/16/2013 | CN102088979B Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin-4-yl] oxy}quinazoline |
10/16/2013 | CN102083799B Benzimidazole derivatives used as FXR agonists |
10/16/2013 | CN102068697B Opiates painkiller and opiate receptor antagonist-containing medicinal composition |
10/16/2013 | CN102065861B Use of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine for treating cognitive deficits |
10/16/2013 | CN102056926B Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
10/16/2013 | CN102030709B Benzazepines compounds serving as vasopressin receptor antagonism |
10/16/2013 | CN101980698B Novel solid forms of bendamustine hydrochloride |
10/16/2013 | CN101952249B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
10/16/2013 | CN101935301B Modulators of ATP-binding cassette transporters |
10/16/2013 | CN101932328B Antiviral agents, antiviral fibers and antiviral fiber structures |
10/16/2013 | CN101883564B Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer |
10/16/2013 | CN101827569B 药物递送系统 Drug delivery system |
10/16/2013 | CN101822652B Vinpocetine transdermal patch and preparation method thereof |
10/16/2013 | CN101817742B Crystal form X of sofalcone, preparation method and use thereof |
10/16/2013 | CN101817741B Crystal form IX of sofalcone, preparation method and use thereof |
10/16/2013 | CN101810862B Tanshinone IIA oral administration polymer micelle composition |
10/16/2013 | CN101801400B Use of yeast flakes for treating and/or preventing hyperinsulinemia |
10/16/2013 | CN101790519B 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
10/16/2013 | CN101605905B Method for glycosylation of flavonoid |
10/16/2013 | CN101600706B Akt活性抑制剂 Akt activity inhibitor |
10/16/2013 | CN101589026B Method of treatment of glioma brain tumour |
10/16/2013 | CN101531657B Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof |
10/16/2013 | CN101528733B 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CBL' receptor modulators |
10/16/2013 | CN101506203B 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other syndromes |
10/16/2013 | CN101490055B Spirocyclic azaindole derivatives |
10/16/2013 | CN101489577B Method and compound for the treatment of valvular disease |
10/16/2013 | CN101378761B Cationic steroid antimicrobial compositions and methods of use |
10/16/2013 | CN101240001B 2'-fluoro nucleotide |
10/16/2013 | CN101208345B (S)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
10/16/2013 | CN101175492B Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
10/16/2013 | CN101039673B Combinations for the treatment of diseases involving cell proliferation |
10/15/2013 | US8558028 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase |
10/15/2013 | US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |